Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T18:47:21.147Z.
Calculation as of: 2026-10-06T18:47:21.147Z.
Quote observation: 2026-10-06T18:44:56.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 8656b7a9da6ad27e4e3bee00a1f051c5b9ad9ad1f17b43070ca9e23e03b297bf
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Market Cap
$406.13M
Free Cash Flow Yield
N/A
TTM Avg
0.27%
3Y Avg
3.53%
5Y Avg
4.14%
Market Cap
$404.81M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$411.43M
Free Cash Flow Yield
N/A
TTM Avg
0.50%
3Y Avg
0.50%
5Y Avg
0.50%
Market Cap
$404.44M
Free Cash Flow Yield
N/A
TTM Avg
24.51%
3Y Avg
24.51%
5Y Avg
24.51%
Market Cap
$413.71M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$415.22M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Neurogene Inc. (NGNE) | $407.95M | N/A | N/A | N/A | N/A |
| Rezolute, Inc. (RZLT)vs › | $407.87M | N/A | N/A | N/A | N/A |
| Myriad Genetics, Inc. (MYGN)vs › | $406.13M | N/A | 0.27% | 3.53% | 4.14% |
| Shoulder Innovations, Inc. (SI)vs › | $404.81M | N/A | N/A | N/A | N/A |
| Strata Critical Medical, Inc. (SRTA)vs › | $411.43M | N/A | 0.50% | 0.50% | 0.50% |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $404.44M | N/A | 24.51% | 24.51% | 24.51% |
| Carlsmed, Inc. (CARL)vs › | $404.24M | N/A | N/A | N/A | N/A |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $413.71M | N/A | N/A | N/A | N/A |
| Senseonics Holdings, Inc. (SENS)vs › | $415.22M | N/A | N/A | N/A | N/A |
| MapLight Therapeutics, Inc. (MPLT)vs › | $415.88M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
